42 results about "Otc drugs" patented technology

An automatic prescription drug dispenser including a remote dispenser, a prescription entry system, and a communications network. The remote dispenser transmits and receives information from the communications network and dispenses prescription drugs to the patient. The prescription entry system transmits and receives information from the communications network and provides an input system for the doctor to electronically enter individual prescriptions for each patient. The communications network coordinates communications between the doctor, insurance carrier, and the remote dispenser. The remote dispenser stores, retrieves, and labels prescription drug and over-the-counter products directly to patients through a remote automated vending machine, a remote dispenser, a prescription entry system, and a communications network.

A device, a system and a computer program are provided for accepting and collecting demographic, OTC drug, prescription, and medical condition data, and outputting nutritional products, recipes, programs, meals, shopping lists, restaurant menus, and the like, designed for each unique user.

Embodiments of the invention provide systems and methods to provide safe, secure and accurate point-to-point delivery of prescription and non-prescription drugs in the long-term home care or ambulatory care environment. More specifically, embodiments of the present invention provide for a low-cost, easy-to-use system comprised of a secure drug dispensing unit and medication enclosure combined with wireless connectivity and software based on smart mobile phone technology. Such systems and methods, referred to herein as a Secure, Control, and Enhance Medication Adherence (SCEMA) system, can mitigate the aforementioned risks associated with the use of prescription and non-prescription drugs. These risks can be significantly reduced for the elderly in the homecare environment, as well as the general public, without disrupting, or a significantly increasing the cost, to the existing prescription and non-prescription drug distribution infrastructure. In addition, the SCEMA system can provide a powerful platform for drug research.

A computer implemented medical record database management system including access by individual patients. A healthcare product or service advertiser can send one or more advertisements to a central server. These advertisements can include, but are not limited to, healthcare products and / or services, medical products and / or services, prescriptions for pharmaceuticals, non-prescription medicines, etc. Each advertisement is linked to one or more key words. These key words generally reference medical conditions. These keys may also relate to pharmaceuticals or other healthcare descriptions. Scripts may also be used in addition to keys to enable more complex correlations of a medical condition or combination of conditions or health information to a particular advertisement. The advertisements may be accessed by individual patients.

A system and method for coordinated evaluation and prescription of unregulated therapeutic substances in a supervised medical environment, wherein the unregulated therapeutic substances, derived from natural products, are initially qualified as a therapeutic option to traditional prescription and OTC medicines. The implementation of the system and method of qualification and prescription of unregulated therapeutic substances is performed within the context of a mainstream medical care environment comprising an established health care management system wherein patient subscribers, within a given system, elect to participate in a trial evaluation under the supervision of the medical professional responsible for their care. Upon successful completion of the evaluation, the patient is empowered, with his medical professional's approval, to adopt the unregulated therapeutic substances for treatment of his illness or condition, and the established health care management system is obligated to reimburse such patient for such unregulated therapeutic substances.

The invention discloses a deep learning based over-the-counter OTC drug recommendation system. The deep learning based over-the-counter drug recommendation system comprises a disease library, a symptom library, an over-the-counter drug library, a data acquisition module, a deep learning data training module, a user information receiving module and a drug recommendation module; the data acquisitionmodule is used for acquiring data information in the disease library, the symptom library and the over-the-counter drug library, and pre-processing and outputting the acquired data; the deep learningdata training module is configured to perform training to form the drug recommendation model according to the data information input by the data acquisition module; the user information receiving module is configured to input the received electronic medical record data into the drug recommendation module; and the drug recommendation module is configured to identify and output a corresponding drugrecommendation result. Compared with the prior art, the beneficial effects of the deep learning based over-the-counter drug recommendation system are that the type of the disease of the patient may be identified according to the symptom characteristics of the patient, and the most appropriate drug is recommended to the patient.

A method of administering an over the counter drug for treatment of a chronic medical condition to a patient is provided wherein a drug label for over-the-counter treatment of a chronic medical condition is created which requires a new patient to take an initial point-of-service diagnostic test to determine whether the patient suffers from the condition treated by the drug and requires patients already receiving the drug on an over-the-counter basis to take one or more follow up point-of-service diagnostic tests to determine whether the patient is benefiting from the drug and are not experiencing undue side effects. Patients determined eligible to take the drug may then be provided with a random access code for use in association with a lockable, electromechanical cabinet by means of which the patient can receive an appropriate dose of the drug to treat the patient's chronic medical condition. In certain embodiments, a follow up point-of-service diagnostic test determines whether the patient is experiencing any undue side effects from the drug. In further embodiments, a national patient registry for containing the point of service diagnostic test results is created for access by appropriate health care professionals.

A pharmacy post office receives prescriptions and produces through an automated pill dispensing and packaging system machine-sortable pharmacy letters that are sortable by automated mail sorting machines into postal delivery routes and delivered as first class or priority mail pieces by the postal delivery persons along their customary routes. A track and trace system may provide a delivery schedule to the patient and / or prescribing doctor based on the time of day the pharmacy letter is provided to the automated mail sorting machines. When a pharmacy letter is delivered by the postal delivery person, he or she scans the tracking code and transmits information back to the track and trace system, which then updates its delivery schedule to show the completed delivery.

A method of preventing the headache phase of migraine in a human comprises administration of a 5HT1 receptor agonist or administration of an over-the-counter or nonprescription drug to said human exhibiting prodrome symptoms of migraine. Suitably, the method comprises administration of a migraine headache phase-preventing effective amount of the 5HT1 agonist or over-the-counter or nonprescription drug. There is disclosed a preemptive prophylaxis migraine method using the following cognitive tests: Simple Reaction Time; Running Memory Continuous Performance Task; Matching to Sample; Mathematical Processing Task; and interpreting the results as a percent of baseline indicator of need for prophylaxis.

A packaging apparatus for packaging OTC drugs, prescription medications (e.g., “starter packs” given to patients by their physicians), or any other suitable object or substance (e.g., tablets, button cell batteries or other small parts or components) is provided. The packaging apparatus combines two thermoforming packaging techniques: clam shell packaging and blister packaging into a single package.

The invention provides an OTC-drug-based recommending system. The OTC-drug-based recommending system includes a symptom characteristic database, a drug database and a drug matching module, wherein thesymptom characteristic database is used for matching the acquired symptom information of users so as to acquire a first set of the corresponding symptom characteristics; the drug database is connected with the symptom characteristic database for acquiring the characteristic weight of each symptom characteristic and acquiring a second set of the drugs corresponding to each symptom characteristic,according to the correlated information between each symptom characteristic in the first set and drugs; and the drug matching module is connected with the drug database for respectively acquiring thematching degree of each drug, according to the characteristic weight and the drugs, in the second set, corresponding to each symptom characteristic. The OTC-drug-based recommending system has the advantages of overcoming the defect that in the prior art, the levels of senior pharmacists are various as drugs are recommended to patients, based on the senior pharmacists, so that the finally recommenddrugs are not surely suitable for the patients.

A container for over-the-counter drugs or the like that includes a cylindrical plastic bottle with a closure. The closure including a cap and a ring that mates with the mouth of the bottle. The cap ring has a tongue that mates with a capture structure on the cap in a child resistant configuration. The tongue being lockable by a pad lock to block access by unwanted adults and teenagers. The tongue having a senior friendly configuration also.

A chewable composition for delivering pharmaceutical compounds. The chewable composition includes a drug delivery vehicle and an active pharmaceutical ingredient. The delivery vehicle may include an organic or non-organic gummy candy. The active ingredient may include an over-the-counter drug or a prescription drug to provide a desired effect on the user. In addition to the active pharmaceutical ingredient, the chewable composition may also include any combination of nutraceuticals, vitamins, minerals, antioxidants, soluble and insoluble fiber, herbs, plants, amino acids, and digestive enzymes.

The present invention is a nonprescription medication consumer tool for selecting nonprescription medications which allows an individual to select his or her symptoms and contraindications to determine a suitable nonprescription medication. The symptoms, contraindications and information provided to the individual, such as dosing and warnings, are provided in layperson's terms. The nonprescription medication consumer tool may be available to individuals as a website and / or mobile device application or as part of a vending system or dispensing machine.

The invention discloses an automatic medicine selling machine, a medicine selling method and a storage medium. The medicine selling method comprises the following steps of receiving medicine purchaserequest information input by a user; according to the medicine purchase request information, determining whether required medicine is prescription medicine or nonprescription medicine; if the medicineis the prescription medicine, through a virtual wisdom pharmacy, transmitting prescription medicine information to a doctor terminal and receiving prescription medicine remark list returned by the doctor terminal; determining whether there is the prescription medicine in the medicine cabinet of the automatic medicine selling machine; and if there is the prescription medicine in the medicine cabinet of the automatic medicine selling machine, conveying the prescription medicine to the medicine outlet of the automatic medicine selling machine so as to output, and printing and outputting the prescription medicine remark list. By using the automatic medicine selling machine, the medicine selling method and the storage medium, after the connection with the doctor terminal, prescription medicineremark information is acquired so as to prevent the improper use of the prescription medicine; and through making an appointment to take the medicine and selecting an optimal route to take the medicine, user time is saved, and a user experience is greatly improved.

A sugar-free chewable composition for delivering dietary supplements and pharmaceutical compounds. The chewable composition includes a sugar-free delivery vehicle and an active ingredient. The delivery vehicle may include a sugar-free gummy candy. The active ingredient may include an over-the-counter drug or a prescription drug to provide a desired effect on the user. The active ingredient may also include any combination of nutraceuticals, vitamins, minerals, antioxidants, soluble and insoluble fiber, herbs, plants, amino acids, probiotics, prebiotics, and digestive enzymes.

Disclosed are an OTC self-help drug selection method and a system, relating to the electrical communication technology and comprising an information interface device, a database, a central processing unit and an output device; the information interface device is interacted with the central processing unit through information to transfer the disease-related information or data; the database stores the data related to disease and other OTC drugs; according to the information or data transferred by the information interface device, the central processing unit obtains the corresponding OTC drug information through the transferring of the database and the internal calculation, and then transfers the OTC drug information to the output device. The method comprises the following steps: A, the user inputs the disease-related information into the information interface device, then the central processing unit obtains the corresponding OTC drug information through the transferring of the database and the internal calculation, according to the information or data transferred by the information interface device; B, the output device outputs the OTC drug information. The method and the system of the invention are safe and accurate and are easy to operate.

A non-prescription medicine sales system is provided. A user can log-in a medicine sales website system, select appropriate medicine and pay required cost; then the user receives the medicine to finish the sales procedure for internal medicine. The man-machine interface of the medicine sales website system is a 3D interface; and the user finishes the whole procedure by operating a computer keyboard or a mouse. The invention adopts dummy 3D cartoon as the special exhibition mode; has a dummy shop sales system for sale of non-prescription internal medicine via internet with the advantages of high repeatability, high interaction, high interesting and high convenience; and can produce huge social value and economic value.

The invention discloses a drug for treating ankylosing spondylitis (AS) and relates to an OTC drug of an orthopaedics, lumbocrural pain and rheumatism class. The drug consists of 33 Chinese medicines of radix polygoni multiflori preparata and the like; and the drug is processed and refined to prepare troches, capsules or pills for oral administration. The drug has mild medicine property, tonifies without causing stagnation, moistens without causing greasiness and has low cost. The drug has functions of nourishing both qi and blood, considering yin and yang, activating collaterals and relieving pain. The drug takes effect after the drug is taken for three days; a patient can recover after two months; and the drug can improve symptoms of a late patient. The drug is in particular suitable for patients with broken sclerotin and stubborn pain. After the patient recovers, the patient takes the drug to prevent diseases. The drug solves the problem that no miracle drug exists for treating AS and also has obvious treatment effect on rheumatism, rheumatoid arthritis and the like.

A mobile device is provided that includes biometric sensor(s), and a processor that causes the biometric sensor(s) to acquire a physiological marker of a user, and identify and authenticate the user. The processor sends a message to an authentication server that indicates the user is authenticated, and receives a response from the authentication server that includes a unique authentication code. The processor receives selection of a thereby selected over-the-counter (OTC) drug, and communicates with a point-of-sale (POS) system with contactless payment capability. The processor sends a purchase message to the POS system that includes the unique authentication code, an identifier of the selected OTC drug, and payment information. And the POS system communicates with the authentication server to validate the unique authentication code, and with an authorization server to authorize payment for the selected OTC drug based on the payment information.

The present invention is directed toward a method of administering an oral solution containing one or more active ingredients, preferably formulations for non-prescription medicines, vital fluids, and / or nutritional supplements, optimally dosed based upon a patient's weight. The method includes providing an oral solution having an effective amount of one or more active ingredients; determining the weight of the individual, preferably to an individual less than 12 years old; and administrating an appropriate amount of the oral solution in a single dose dispensing unit in accordance with the weight determination of the individual, whereby the total amount of active ingredient administered corresponds to an effective amount of the active ingredient based on the individual's weight.

A method of administering an over the counter drug for treatment of a chronic medical condition to a patient is provided wherein a drug label for over-the-counter treatment of a chronic medical condition is created which requires a new patient to take an initial point-of-service diagnostic test to determine whether the patient suffers from the condition treated by the drug and requires patients already receiving the drug on an over-the-counter basis to take one or more follow up point-of-service diagnostic tests to determine whether the patient is benefiting from the drug and are not experiencing undue side effects. Patients determined eligible to take the drug may then be provided with a random access code for use in association with a lockable, electromechanical cabinet by means of which the patient can receive an appropriate dose of the drug to treat the patient's chronic medical condition. In certain embodiments, a follow up point-of-service diagnostic test determines whether the patient is experiencing any undue side effects from the drug. In further embodiments, a national patient registry for containing the point of service diagnostic test results is created for access by appropriate health care professionals.

The invention discloses a health insurance and mobile medical health service combined operation mode. The operation mode comprises the following specific steps of 1, inputting own disease symptom or symptom condition by a user; 2, when the user inputs the own disease symptom, if a slight disease or symptom condition defined by software according to a database model is met, giving corresponding disease symptom information, health suggestions and drug information, and providing OTC drugs through a cooperative drug suppliers; and 3, if the condition of an input interface of the user does not belong to the slight disease or symptom condition, providing hospital and department introduction selection, doctor-seeing suggestion and doctor-seeing service reservation functions by the software, and compensating medical expenses according to the regulations of health insurance. According to the operation mode, the operation is simple and convenient; the health suggestions and the drug information are provided for the user in combination with a manual mode through an online database; and the user selects different forms and different solutions of the medical expenses according to own actual situations.

The invention provides a hemorrhoid comforting lotion which is a surgery hemorrhoid OTC drug and can clear heat and dry damp, remove blood stasis to detoxicate, stanch to reduce the swelling, and relive pain and itch as well as is used for the acute bout of hemorrhoid. The quality standard of the prior hemorrhoid comforting lotion can not respond the qualitative method of liquorice and sophora japonica. The invention aims to provide a perfect quality control method for the hemorrhoid comforting lotion on the aspects of liquorice and sophora japonica qualitative analysis and osthole quantity analysis. On the basis of the qualitative method and the quantitative method of the invention, the hemorrhoid comforting lotion provides better guarantee for the production, the circulation and the clinical application of the hemorrhoid comforting lotion.

A method of administering an over the counter drug for treatment of a chronic medical condition to a patient is provided wherein a drug label for over-the-counter treatment of a chronic medical condition is created which requires a new patient to take an initial point-of-service diagnostic test to determine whether the patient suffers from the condition treated by the drug and requires patients already receiving the drug on an over-the-counter basis to take one or more follow up point-of-service diagnostic tests to determine whether the patient is benefiting from the drug and are not experiencing undue side effects. Patients determined eligible to take the drug may then be provided with a random access code for use in association with a lockable, electromechanical cabinet by means of which the patient can receive an appropriate dose of the drug to treat the patient's chronic medical condition. In certain embodiments, a follow up point-of-service diagnostic test determines whether the patient is experiencing any undue side effects from the drug. In further embodiments, a national patient registry for containing the point of service diagnostic test results is created for access by appropriate health care professionals.

Disclosed is a medical scheduling system to keep the users of medically prescribed medication on their medication-taking schedule. The Med-Sked™ Tab System is a series of Day / Dose tabs that indicate the medication schedule or calendar and confirms that the schedule has been adhered to, when the appropriate tabs are removed. This procedure eliminates the confusion associated with the taking of medication. It assists the user in complying with, and with specificity to prescription and non-prescription medication scheduling. Using a tab residue, It confirms that this has been accomplished when the appropriate Day / Dose Tab has been removed.

Herein is a complete medical care system utilizing a medicine organizer bag containing a diverse assortment of OTC medicines (akin to a pharmacy). The medicine organizer bag is used in conjunction with an instructional App and website that navigates one to the proper medicine based on a person's symptoms and utilizing manufacturer's product information or virtual physician link to address common illnesses. The briefcase formed of first and second sections defining an interior volume and closed with a flap. The interior volume is closed by a zippered securement. A first interior wall is disposed within the first section, and a second interior wall disposed within the second section, each containing medicine holders. The plurality of medicine holders each includes an identifier. A third interior wall is adjacent to the first interior wall within the flap. A removable interior detachable travel component is adapted to be removably secured within the briefcase.

A method is provided for authenticating, and establishing and tracking eligibility of a patient to purchase an over-the-counter (OTC) dmg from a retailer, the patient using a client device or terminal and the retailer having a server. The server is 5 configured to redirect the client device or terminal to a backend platform to authenticate the patient, access a storage to search for any information that indicates the patient is ineligible to purchase the OTC drug; and without any information that indicates the patient is ineligible, administer a questionnaire to the patient to assess the eligibility for the OTC drug. And the backend platform redirects the client device 10 or terminal back to the server to complete the online sale of the OTC drug to the patient when the patient is eligible, or cancel the online sale of the OTC dmg to the patient when the patient is ineligible.